These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15584983)

  • 21. Underestimation of the expression of cellular prion protein on human red blood cells.
    Panigaj M; Brouckova A; Glierova H; Dvorakova E; Simak J; Vostal JG; Holada K
    Transfusion; 2011 May; 51(5):1012-21. PubMed ID: 21058954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML; Ludlam CA
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current strategies to prevent transmission of prions by human plasma derivatives.
    Burnouf T; Padilla A
    Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.
    Cervia JS; Sowemimo-Coker SO; Ortolano GA; Wilkins K; Schaffer J; Wortham ST
    Transfus Med Rev; 2006 Jul; 20(3):190-206. PubMed ID: 16787827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples.
    Guntz P; Walter C; Schosseler P; Morel P; Coste J; Cazenave JP
    Transfusion; 2010 May; 50(5):989-95. PubMed ID: 20088835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood reference materials from macaques infected with variant Creutzfeldt-Jakob disease agent.
    McDowell KL; Nag N; Franco Z; Bu M; Piccardo P; Cervenak J; Deslys JP; Comoy E; Asher DM; Gregori L
    Transfusion; 2015 Feb; 55(2):405-12. PubMed ID: 25154296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.
    Brown P; Cervenáková L; McShane LM; Barber P; Rubenstein R; Drohan WN
    Transfusion; 1999; 39(11-12):1169-78. PubMed ID: 10604242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of misfolded prion protein in blood with conformationally sensitive peptides.
    Pan T; Sethi J; Nelsen C; Rudolph A; Cervenakova L; Brown P; Orser CS
    Transfusion; 2007 Aug; 47(8):1418-25. PubMed ID: 17655586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues.
    Bruce ME; McConnell I; Will RG; Ironside JW
    Lancet; 2001 Jul; 358(9277):208-9. PubMed ID: 11476840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
    Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
    Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal.
    Flan B; Arrabal S
    Transfus Clin Biol; 2007 May; 14(1):51-62. PubMed ID: 17540602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient detection of PrPSc (263K) in human plasma.
    Fujita R; Urayama T; Ohmizu A; Yunoki M; Tsuji S; Ikuta K
    Biologicals; 2006 Sep; 34(3):187-9. PubMed ID: 16257541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of blood-borne Creutzfeldt--Jakob disease.
    Brown P
    Dev Biol (Basel); 2000; 102():53-9. PubMed ID: 10794090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of prion protein in the gut of mice infected orally with the 301V murine strain of the bovine spongiform encephalopathy agent.
    González L; Terry L; Jeffrey M
    J Comp Pathol; 2005 May; 132(4):273-82. PubMed ID: 15893985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technical aspects of the development and validation of tests for variant Creutzfeldt-Jakob disease in blood transfusion.
    Minor PD
    Vox Sang; 2004 Apr; 86(3):164-70. PubMed ID: 15078250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative bioassay of surface-bound prion infectivity.
    Lawson VA
    Methods Mol Biol; 2008; 459():265-73. PubMed ID: 18576161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classification of sporadic Creutzfeldt-Jakob disease revisited.
    Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
    Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity.
    Lewis V; Haigh CL; Masters CL; Hill AF; Lawson VA; Collins SJ
    Mol Neurodegener; 2012 Apr; 7():18. PubMed ID: 22534096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of the effects of several chemical and physical treatments on the activity of protease resistance and infectivity of scrapie strain 263K.
    Yao HL; Han J; Gao JM; Zhang J; Zhang BY; Guo YJ; Nie K; Gao C; Wang XF; Dong XP
    J Vet Med B Infect Dis Vet Public Health; 2005 Dec; 52(10):437-43. PubMed ID: 16364019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.